Potent Weight Loss and Favorable Glycemic Control Effects of a Novel Long-Acting GLP-1/GIP/GCG Triple Agonist, HM15275, in Animal Models

被引：0
|
作者：
Park, Sang Hyun
Kim, Yohan
Kim, Jung Kuk
Lee, Dahae
Park, Eunjin
Kim, Jeong A.
Hong, Sunghee
Choi, Jaehyuk
Bae, Sungmin
Lee, Sang Hyun
Choi, In Young
机构：
来源：
DIABETES | 2024年 / 73卷
关键词：
D O I：
10.2337/db24-776-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
776-P
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Potent Weight Loss Effect and Mechanism of a Novel Long-acting GLP-1/GIP/GCG Triple Agonist, HM15275, in Animal Model of Obesity
    Kim, Jung Kuk
    Kim, Yohan
    Park, Sang Hyun
    Park, Eun Jin
    Lee, Dahae
    Kim, Jeong
    Hong, Sung Hee
    Bae, Sungmin
    Lee, Sang Hyun
    Choi, In Young
    OBESITY, 2024, 32 : 188 - 188
  • [2] Potential Cardioprotective Effects of HM15275, a Novel, Long-Acting GLP-1/GIP/GCG Triple Agonist, in Animal Models of Hypertension
    Lee, Seon Myeong
    Kim, Jung Kuk
    Park, Eunjin
    Kang, Hye Reyeon
    Kim, Jeong A.
    Kim, Yohan
    Hong, Sunghee
    Bae, Sungmin
    Lee, Sang Hyun
    Choi, In Young
    DIABETES, 2024, 73
  • [3] Therapeutic Potential of HM15275, a Novel Long-Acting GLP-1/GIP/GCG Triple Agonist, in Animal Models of Heart Failure
    Ye, Byeongjin
    Kim, Wonki
    Lee, Seon Myeong
    Kim, Jeong A.
    Kim, Eunseon
    Bae, Sungmin
    Lee, Sang Hyun
    Choi, In Young
    DIABETES, 2024, 73
  • [4] Nephroprotective Effects of a Novel Long-Acting GLP-1/GIP/GCG Triple Agonist, HM15275, in Preclinical Models of Acute and Chronic Kidney Diseases
    Lee, Seon Myeong
    Park, Eunjin
    Kim, Jung Kuk
    Kang, Hye Reyeon
    Kim, Jeong A.
    Kim, Yohan
    Hong, Sunghee
    Bae, Sungmin
    Lee, Sang Hyun
    Choi, In Young
    DIABETES, 2024, 73
  • [5] Effect of a novel long-acting GLP-1/GIP/glucagon triple agonist (HM15211) in a dyslipidaemia animal models
    Jo, H.
    Kim, J.
    Choi, J.
    Lee, S.
    Lee, S. -H.
    Choi, I.
    DIABETOLOGIA, 2019, 62 : S510 - S511
  • [6] Neuroprotective effects of HM15211, a novel long-acting GLP-1/GIP/Glucagon triple agonist in the neurodegenerative disease models
    Kim, W.
    Kim, J.
    Lee, S. -H.
    Bae, S.
    Choi, I.
    Kim, Y.
    DIABETOLOGIA, 2019, 62 : S292 - S292
  • [7] Neuroprotective Effects of HM15211, a Novel Long-Acting GLP-1/GIP/Glucagon Triple Agonist in the Neurodegenerative Disease Models
    Kim, Jeong A.
    Lee, Sangdon
    Lee, Sang Hyun
    Jung, Sung Youb
    Kim, Young Hoon
    Choi, In Young
    Kim, Sun Jin
    DIABETES, 2018, 67
  • [8] Neuroprotective effects of HM15211, a novel long-acting GLP-1/GIP/glucagon triple agonist in the neurodegenerative disease models
    Kim, J.
    Lee, S.
    Lee, S. -H.
    Jung, S.
    Kim, Y.
    Choi, I.
    Kim, S.
    DIABETOLOGIA, 2018, 61 : S84 - S85
  • [9] Effect of a novel long-acting GLP-1/GIP/Glucagon triple agonist (HM15211) in NASH and liver fibrosis animal models
    Kim, J.
    Lee, J.
    Kim, D.
    Park, E.
    Kim, Y.
    Choi, I.
    DIABETOLOGIA, 2019, 62 : S531 - S532
  • [10] Therapeutic effect of a novel long-acting GLP-1/GIP/Glucagon triple agonist (HM15211) in NASH and fibrosis animal models
    Kim, J.
    Choi, I.
    Lee, J.
    Park, E.
    Kim, Y.
    Jung, S.
    Kim, S.
    DIABETOLOGIA, 2018, 61 : S61 - S62
12345